IL1R2 and non-small cell lung carcinoma: In addition, as reported above, IL-1R2 recently emerged as a tumor-infiltrating Treg associated marker in scRNA sequencing studies, in breast, colorectal or non-small-cell lung cancers, together with several immune-checkpoints (50, 51).